http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011011984-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10 |
| filingDate | 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c2bb08f9d7c23b751cfb7a7dbafafc |
| publicationDate | 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011011984-A |
| titleOfInvention | Pseudomyopia treatment |
| abstract | It is an object of the present invention to provide a pseudomyopia therapeutic drug containing tropicamide that has almost no mydriatic action when tropicamide is instilled, improves an unpleasant irritation, and is excellent in use feeling. The present invention includes (A) tropicamide or a salt thereof and (B) an α-adrenergic receptor antagonist, wherein (A) the content of the component is 0.001 W / V% to 0.1 W / V%. Myopia treatment. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021514995-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7160934-B2 |
| priorityDate | 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 337.